Filters close
Released: 21-Oct-2022 1:50 PM EDT
Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19
JAMA - Journal of the American Medical Association

Among outpatients with mild to moderate COVID-19, treatment with ivermectin, compared with placebo, did not significantly improve time to recovery in this trial that enrolled more than 1,500 participants in the United States.

Released: 18-Oct-2022 4:05 PM EDT
Comparative safety of Pfizer-BioNTech COVID-19 vaccine vs non–SARS-CoV-2 vaccines in children younger than age 5
JAMA - Journal of the American Medical Association

The symptoms reported after administration of the Pfizer-BioNTech COVID-19 vaccine were comparable overall to those for approved non–SARS-CoV-2 vaccines in this study including 7,800 children younger than age 5.

Released: 11-Oct-2022 4:50 PM EDT
Algorithm for predicting biological age has been developed
Universidad Carlos III de Madrid

According to information provided by the Spanish National Institute of Statistics (INE, in its Spanish acronym), the ageing rate of the Spanish population rose from 0.908 in 1997 to 1.183 in 2017. In turn, life expectancy increased exponentially over the same period of time.

Released: 6-Oct-2022 3:55 PM EDT
Archaeology: Modern pesticide accelerates corrosion of ancient Roman bowl
Scientific Reports

A corroded Roman bowl dated to the Late Iron Age (between 43 and 410 AD) contains traces of chlorobenzenes, a chemical once used in pesticides that is known to accumulate in soil and water sources.

Released: 4-Oct-2022 6:00 PM EDT
A Need to Consistently Characterize Aerosol Research Associated with E-cigarettes Is Featured in New Issue of ToxSci
Society of Toxicology

Other featured research in October 2022 issue involves an exploration of a pharmacokinetic model for quantifying the mother-to-child transfer of environmental chemicals and how febuxostat may increase the risk for cardiovascular events by dysregulating calcium dynamics.

29-Sep-2022 5:05 PM EDT
Incidence of Myocarditis/Pericarditis Following mRNA COVID-19 Vaccination Among Children and Younger Adults in the United States
American College of Physicians (ACP)

In this population-based surveillance, the authors found that myocarditis/pericarditis 0 to 7 days after mRNA vaccination in persons aged 5 to 39 years occurred in approximately 1 in 200,000 doses after the first dose and 1 in 30,000 doses after second dose of the primary series, and 1 in 50,000 doses after the first booster. The incidence varied markedly by age and sex, however, with a disproportionate number of cases occurring in male persons, notably among adolescents after dose 2 and first boosters.

30-Sep-2022 11:00 AM EDT
Texas Tech Scientists Explore Ability to Adapt and Survive
Texas Tech University

Scientists have discovered the origins of how animals adapt to and live in freshwater.

Released: 27-Sep-2022 1:50 PM EDT
Combined human and veterinary services enhance primary care access for homeless youth and their pets
American Academy of Family Physicians (AAFP)

In 2018, a multidisciplinary team in Seattle created a combined clinical space to care for homeless youth and their pets.

   
Released: 19-Sep-2022 3:05 PM EDT
Gene regulation: DNA modification important for silencing of endogenous retroviruses
Ludwig-Maximilians-Universität München (Munich)

LMU molecular biologist Gunnar Schotta has investigated which mechanisms prevent endogenous retroviruses from becoming overly active.

Released: 19-Sep-2022 10:45 AM EDT
Scientists identify potential vaccine target for increasingly concerning bacterial strain
Wiley

Acinetobacter baumannii is a bacterial pathogen responsible for serious hospital-related infections that is becoming increasingly resistant against antibiotics.

14-Sep-2022 2:15 PM EDT
NEJM: Cerebral Embolic Protection During Transcatheter Aortic-Valve Replacement
Cedars-Sinai

A study published today in the New England Journal of Medicine (NEJM) found that among patients with aortic stenosis undergoing transfemoral TAVR, the use of a debris capturing device called cerebral embolic protection reduced the risk of disabling stroke from 1.3% to 0.5%.

Released: 15-Sep-2022 12:05 PM EDT
Artificial Intelligence Shown to More Rapidly and Objectively Determine Calcium Scores Than Physicians
Cedars-Sinai

A study published today in the Journal of the American College of Cardiology (JACC): Cardiovascular Imaging shows that artificial intelligence tools can more rapidly, and objectively, determine calcium scores in computed tomographic (CT) and positron emission tomographic (PET) images than physicians, even when obtained from very-low-radiation CT attenuation scans.



close
0.43098